Ra Capital Management, L.P. Seres Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $27.9 Million - $115 Million	-5,105,547 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $26.1 Million - $34.4 Million	1,411,354 Added 38.2%	5,105,547 $1.9 Million
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $65.2 Million - $107 Million	3,694,193 New	3,694,193 $76.1 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $110 Million - $179 Million	-4,750,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $17.8 Million - $137 Million	4,750,000 New	4,750,000 $134 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $120M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.